The secreted cathepsins are recognised as effectors, which can modify the tumour microenvironment through the turnover and degradation of the extracellular matrix (ECM) [24], and by processing, activating or degrading various cytokines, growth factors, and chemokines [25, 26]. This evidence concerns the gene CTSS and neoplasm.